STRATA Skin Sciences rises on agreement to enter Indian market
** Shares of medtech co STRATA Skin Sciences Inc SSKN.O
rise 2.3% to $1.05
** Co says it has entered into an exclusive, three-year
agreement with Indian co Spectra Medical India Pvt Ltd
** The agreement is for the distribution of its acne
treatment system TheraClearX, VTRAC lamp systems, and psoriasis
and vitiligo treatment laser XTRAC in India
** Co expects to receive regulatory approval in India
during Dec 2023
** Stock up ~33% YTD
(Reporting by Sriparna Roy in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))
Recent news on STRATA Skin Sciences
See all newsBrief: Strata Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan As Chief Executive Officer
Brief: Laseroptek America Filed Counterclaims & Third-Party Claims Against Strata Skin Sciences & Its CEO, In Lawsuit Brought By Strata
Medical tech firm STRATA's Q3 revenue misses estimates as demand in international markets softens
Brief: STRATA Skin Sciences Q3 Revenue USD 6.9 Million
Brief: STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions